QT Dispersion After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial

Kyaw Thiri Tun1,2, Khaing Khaing Shein3

  • 1Acute Medicine, North West Anglia NHS Foundation Trust, Peterborough, GBR.

Cureus
|August 4, 2026
PubMed

Insights

QT dispersion (QTd) after primary percutaneous coronary intervention (PPCI) in ST-segment elevation myocardial infarction (STEMI) patients is linked to adverse in-hospital events. Higher QTd (>50 ms) indicates increased risk of cardiogenic shock and heart failure.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Critical Care Medicine

Background:

  • Acute myocardial infarction (AMI) is a leading global cause of death, with complications like arrhythmia and cardiogenic shock significantly impacting outcomes.
  • QT dispersion (QTd), a measure of ventricular electrical heterogeneity, is a potential predictor of cardiac events, but its role after reperfusion therapy is debated.
  • Identifying reliable markers for predicting adverse outcomes post-reperfusion in ST-segment elevation myocardial infarction (STEMI) remains crucial.

Purpose of the Study:

  • To investigate the association between QT dispersion (QTd) measured after primary percutaneous coronary intervention (PPCI).
  • To evaluate the relationship between QTd and reperfusion status in STEMI patients.
  • To assess the correlation of QTd with in-hospital complications following PPCI.

Main Methods:

  • 108 STEMI patients undergoing PPCI were included in the study.
  • A 12-lead electrocardiogram (ECG) was recorded one hour post-PPCI.
  • QT intervals were manually measured, corrected using the Fridericia formula (QTc), and QT dispersion (QTd) was calculated as the difference between maximum and minimum QTc intervals.

Main Results:

  • No significant association was found between QTd and ST-segment resolution (STR) or Thrombolysis In Myocardial Infarction (TIMI) flow.
  • Patients with QTd >50 ms exhibited significantly higher rates of cardiogenic shock (48% vs 5.2%), heart failure (12% vs 0%), and reduced ejection fraction (EF) (52% vs 19%) compared to those with QTd ≤50 ms.
  • Ventricular tachycardia and post-infarction angina were observed more frequently in the higher QTd group, though not statistically significant due to sample size.

Conclusions:

  • QT dispersion (QTd) is significantly associated with adverse in-hospital outcomes, including cardiogenic shock, heart failure, and reduced ejection fraction (<50%) in STEMI patients post-PPCI.
  • QTd may serve as a valuable non-invasive marker for assessing myocardial electrical instability.
  • This parameter could help identify STEMI patients at higher risk for adverse complications, guiding clinical management.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...